Wednesday, October 4, 2023
Wednesday, October 4, 2023

Contact: 561.316.3330

Frost & Sullivan Presents the Unprecedented Opportunities in the Personal Protection Equipment Industry

The COVID-19 pandemic has caught the world by surprise, and a shortage of personal protective equipment (PPE) has exposed the vulnerability of our healthcare and emergency response systems. While the virus has uncovered industry shortcomings, such as its dependence on outsourced supply chains, demand for PPE is thriving and creating market opportunities globally.

According to Frost & Sullivan, on average, the industry grows at 3% to 5% per annum; however, the healthcare PPE segment is now experiencing an unprecedented boom, estimated at 80% to 100%, and is opening doors for new entrants, alliances, and partnership opportunities between PPE players and material suppliers.

Frost & Sullivan invites you to join Global President & Managing Partner Aroop Zutshi and Vice President Sanjiv Bhaskar for the Growth Opportunity briefing, “COVID-19: Growth Opportunities in the PPE Industry,” on May 7 at 11 a.m. EST.

Frost & Sullivan notes the briefing will highlight how the PPE industry can seize the growth opportunities presented and remain a favorite of the private equity community, and also discuss how the pandemic will change the PPE industry’s approach to different end-user industries.

For more information and to register for the webinar, please visit: http://frost.ly/42t

Key benefits of attending this webinar:

  • Understand the impact of COVID-19 on the industrial PPE markets.
  • Identify global opportunities for industrial PPE supplies of masks, gowns and eye protection in the healthcare industry.
  • Expose potential new competitors to industrial PPE players.
  • Discover how to overcome supply chain challenges such as over-dependence on imports.
  • Capitalize on the growing userbase to help your company expand.
  • Find out if COVID-19 will reverse the PPE consolidation trend or enhance it.

 

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy